Cardiovascular Safety and Superiority of Anti-Obesity Medications

Over the past few decades, several anti-obesity medications have demonstrated an association with adverse cardiovascular outcomes, leading to their market withdrawal. This has caused researchers to investigate the cardiovascular safety of such medications in cardiovascular outcome trials. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alobaida, Muath, Alrumayh, Abdullah, Oguntade, Ayodipupo S, Al-Amodi, Faez, Bwalya, Mwango
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286099/
https://www.ncbi.nlm.nih.gov/pubmed/34285527
http://dx.doi.org/10.2147/DMSO.S311359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286099/
https://www.ncbi.nlm.nih.gov/pubmed/34285527
http://dx.doi.org/10.2147/DMSO.S311359

Ejemplares similares